NCT00290329 - Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years | Biotech Hunter

Enrollment

249

Participants

Timeline

Start Date

January 14, 2006

Primary Completion Date

October 1, 2006

Study Completion Date

October 17, 2006

Conditions

Infections, Meningococcal

Interventions

BIOLOGICAL

Mencevax ACWY

1 subcutaneous injection.

Trial Locations (8)

GSK Investigational Site, Manila

GSK Investigational Site, Alabang, Muntinlupa City

GSK Investigational Site, City of Muntinlupa

GSK Investigational Site, Los Banos, Laguna

GSK Investigational Site, Binangonan, Rizal

GSK Investigational Site, Cainta, Rizal

GSK Investigational Site, Las Piñas

GSK Investigational Site, Pasay